Please note, this is our interim website. Some content may not be available however if you need assistance, please contact us.
List of Detailed Financial Policies
The CCG is required to follow, and accordingly recognises, a number of national policies and other requirements relating to NHS Finance.
For example, it follows the financial reporting requirements for the whole of government set by the Treasury, and the specific requirements of the Department of Health and NHS England within this overall accounting framework.
The CCG participates in a number of shared financial service arrangements, under which the CCG contracts with providers through an agreed service level which is underpinned by the professional policies and standards maintained by those providers.
For example, the CCG uses the national accounting platform and accounting services provided by NHS Shared Business Services. The CCG has also engaged the Midlands & Lancashire Commissioning Support Unit, which provides a range of financial services.
In addition, the CCG has put in place a number of detailed financial policies covering:
- Control Account Reconciliations
- Capital Charges and the Asset Register
- Disposal of Surplus, Obsolete and Scrap Items
- Monitoring of Capital Expenditure
- Losses and Special Payments
- Authorised Signatory List
- Lost and Found Property
The Procurement Strategy is in the process of being updated and will be published shortly.
- Declaration of Gifts, Hospitality and Sponsorship – Anti-Bribery Policy and Procedure
This document sets out Shropshire CCG’s policy and procedure for dealing with the requirements of the Bribery Act 2010, regarding the acceptance of gifts, hospitality and corporate sponsorship.
- Policy and Guidance for joint working with the pharmaceutical industry (including rebate schemes) and commercial sponsorship of meetings and training events
This document provides a framework to assist the organisation and NHS staff in determining when commercial sponsorship or a joint agreement is appropriate when working with the pharmaceutical industry.